OSCR
$31.89-4.72%
as of close, Oct 16, 2026
☾ AH $31.89 -4.72%
OSCR SEC filings (2026)
CIK 1568651 · Hospital & Medical Service Plans (SIC 6324) · incorporated in DE · fiscal year ends in December
586 filings on EDGAR since 2013 · 6 annual, 17 quarterly, 62 current · financial statements · earnings
Latest 10-K
Feb 13, 2026
fiscal year to Dec 31, 2025
Latest 10-Q
Aug 7, 2026
quarter to Jun 30, 2026
Latest 8-K
Sep 16, 2026
Regulation FD disclosure
Last earnings release
Aug 6, 2026
$1.10 vs $0.43 · ▼ 11.9%
Filings on file
586
since 2013, 406 insider forms
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
September 2026
- Sep 18Insider saleWITTMAN VANESSA AMES (Director) sold 25,000 Class A shares for $806K at $32.24 under a 10b5-1 plan
- Sep 168-K8-K · Regulation FD disclosure
- Sep 3Insider saleSchlosser Mario (Director) sold 31,422 Class A shares for $988K at $31.45 under a 10b5-1 plan
- Sep 3Insider saleBlackley Richard Scott (Chief Financial Officer) sold 28,869 Class A shares for $908K at $31.45 under a 10b5-1 plan
- Sep 3Insider saleLiang Janet (President, Oscar Insurance) sold 10,360 Class A shares for $326K at $31.45 under a 10b5-1 plan
- Sep 3Insider saleMcAnaney Adam (Chief Legal Officer) sold 9,092 Class A shares for $286K at $31.45 under a 10b5-1 plan
- Sep 3Insider saleBaltrus Victoria (Chief Accounting Officer) sold 958 Class A shares for $30K at $31.45 under a 10b5-1 plan
August 2026
- Aug 28Insider saleSchlosser Mario (Director) sold 150,000 Class A shares for $4.6M at $30.79
- Aug 27Insider saleSchlosser Mario (Director) sold 600,000 Class A shares for $18.2M at $30.34
- Aug 18Insider saleBlackley Richard Scott (Chief Financial Officer) sold 18,750 Class A shares for $595K at $31.74
- Aug 7ReportQuarterly report, Q2 2026 — revenue $4.88B (+70% y/y), net income $361.8M, EPS $1.10
- Aug 6EarningsEarnings release — EPS $1.10 vs $0.43 est. (+155.8%); revenue $4.88B (+70% y/y) 11.9%
July 2026
June 2026
- Jun 30Insider saleBertolini Mark T (Chief Executive Officer · Director) sold 624,244 Class A shares for $17.8M at $28.35–$28.97 under a 10b5-1 plan
- Jun 29Insider saleBertolini Mark T (Chief Executive Officer · Director) sold 614,752 Class A shares for $18.0M at $29.17–$30.08 under a 10b5-1 plan
- Jun 26Insider saleBertolini Mark T (Chief Executive Officer · Director) sold 591,168 Class A shares for $17.3M at $29.11–$29.79 under a 10b5-1 plan
- Jun 25Insider saleBertolini Mark T (Chief Executive Officer · Director) sold 615,142 Class A shares for $17.6M at $28.60–$29.08 under a 10b5-1 plan
- Jun 23Insider saleSchlosser Mario (Director) sold 1,027,500 Class A shares for $30.2M at $28.95–$30.09 under a 10b5-1 plan
- Jun 98-K8-K · Shareholder vote results
- Jun 88-K8-K · Regulation FD disclosure
- Jun 2Insider saleSchlosser Mario (Director) sold 34,120 Class A shares for $749K at $21.74–$22.45 under a 10b5-1 plan
- Jun 2Insider saleBlackley Richard Scott (Chief Financial Officer) sold 31,683 Class A shares for $695K at $21.74–$22.45 under a 10b5-1 plan
- Jun 2Insider saleLiang Janet (President, Oscar Insurance) sold 12,475 Class A shares for $274K at $21.74–$22.45 under a 10b5-1 plan
- Jun 2Insider saleMcAnaney Adam (Chief Legal Officer) sold 9,859 Class A shares for $216K at $21.74–$22.45 under a 10b5-1 plan
- Jun 2Insider saleBaltrus Victoria (Chief Accounting Officer) sold 1,523 Class A shares for $33K at $21.74–$22.45 under a 10b5-1 plan
- Jun 28-K8-K · Directors or officers; compensation
May 2026
- May 18Insider saleBlackley Richard Scott (Chief Financial Officer) sold 110,000 Class A shares for $2.8M at $25.03 under a 10b5-1 plan
- May 14Insider saleBlackley Richard Scott (Chief Financial Officer) sold 100,000 Class A shares for $2.3M at $23.10–$23.79 under a 10b5-1 plan
- May 7ReportQuarterly report, Q1 2026 — revenue $4.65B (+53% y/y), net income $679.0M, EPS $2.07
- May 6EarningsEarnings release — EPS $2.07 vs $1.21 est. (+71.1%); revenue $4.65B (+53% y/y) 10.6%
April 2026
- Apr 22ProxyProxy · Annual report to shareholders
- Apr 22ProxyProxy · Additional proxy materials
- Apr 22ProxyProxy · Proxy statement
- Apr 218-K8-K · Oscar Health, Inc. Appoints Director Siddhartha Sankaran as Independent Chair of the BoardRegulation FD disclosure
- Apr 6Insider buyBertolini Mark T (Chief Executive Officer · Director) bought 1,000,000 Class A shares for $11.9M at $11.92
March 2026
- Mar 2Insider saleSchlosser Mario (President of Technology & CTO · Director) sold 24,335 Class A shares for $326K at $13.39 under a 10b5-1 plan
- Mar 2Insider saleBlackley Richard Scott (Chief Financial Officer) sold 19,221 Class A shares for $257K at $13.39 under a 10b5-1 plan
- Mar 2Insider saleMcAnaney Adam (Chief Legal Officer) sold 18,710 Class A shares for $251K at $13.39 under a 10b5-1 plan
- Mar 2Insider saleLiang Janet (President, Oscar Insurance) sold 7,453 Class A shares for $100K at $13.39 under a 10b5-1 plan
- Mar 2Insider saleBaltrus Victoria (Chief Accounting Officer) sold 4,638 Class A shares for $62K at $13.39 under a 10b5-1 plan
- Mar 28-K8-K · Regulation FD disclosure
February 2026
January 2026
- Jan 8Insider saleSchlosser Mario (President of Technology & CTO · Director) sold 23,038 Class A shares for $407K at $17.65 under a 10b5-1 plan
- Jan 6Insider saleSchlosser Mario (President of Technology & CTO · Director) sold 76,962 Class A shares for $1.3M at $17.01 under a 10b5-1 plan
- Jan 5Insider saleSchlosser Mario (President of Technology & CTO · Director) sold 96,928 Class A shares for $1.5M at $15.64 under a 10b5-1 plan
- Jan 2Insider saleSchlosser Mario (President of Technology & CTO · Director) sold 137,933 Class A shares for $2.1M at $15.02 under a 10b5-1 plan
December 2025
- Dec 298-K8-K · Directors or officers; compensation
November 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $142.4M in 31 sales and bought $11.9M in 1 purchase; 51 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Sep 18, 2026Form 4 | WITTMAN VANESSA AMESDirectorSold · Class A · $806K · 25,000 sh · 10b5-1 |
| Sep 3, 2026Form 4 | Schlosser MarioDirectorSold · Class A · $988K · 31,422 sh · 10b5-1 |
| Sep 3, 2026Form 4 | Blackley Richard ScottChief Financial OfficerSold · Class A · $908K · 28,869 sh · 10b5-1 |
| Sep 3, 2026Form 4 | Liang JanetPresident, Oscar InsuranceSold · Class A · $326K · 10,360 sh · 10b5-1 |
| Sep 3, 2026Form 4 | McAnaney AdamChief Legal OfficerSold · Class A · $286K · 9,092 sh · 10b5-1 |
| Sep 3, 2026Form 4 | Baltrus VictoriaChief Accounting OfficerSold · Class A · $30K · 958 sh · 10b5-1 |
| Aug 28, 2026Form 4 | Schlosser MarioDirectorSold · Class A · $4.6M · 150,000 sh |
| Aug 27, 2026Form 4 | Schlosser MarioDirectorSold · Class A · $18.2M · 600,000 sh |
| Aug 18, 2026Form 4 | Blackley Richard ScottChief Financial OfficerSold · Class A · $595K · 18,750 sh |
| Jul 1, 2026Form 4 | Schlosser MarioDirectorSold · Class A · $1.5M · 47,500 sh · 10b5-1 |
| Jun 30, 2026Form 4 | Bertolini Mark TChief Executive Officer · DirectorSold · Class A · $17.8M · 624,244 sh · 10b5-1 |
| Jun 29, 2026Form 4 | Bertolini Mark TChief Executive Officer · DirectorSold · Class A · $18.0M · 614,752 sh · 10b5-1 |
| Jun 26, 2026Form 4 | Bertolini Mark TChief Executive Officer · DirectorSold · Class A · $17.3M · 591,168 sh · 10b5-1 |
| Jun 25, 2026Form 4 | Bertolini Mark TChief Executive Officer · DirectorSold · Class A · $17.6M · 615,142 sh · 10b5-1 |
| Jun 23, 2026Form 4 | Schlosser MarioDirectorSold · Class A · $30.2M · 1,027,500 sh · 10b5-1 |
| Jun 2, 2026Form 4 | Schlosser MarioDirectorSold · Class A · $749K · 34,120 sh · 10b5-1 |
| Jun 2, 2026Form 4 | Blackley Richard ScottChief Financial OfficerSold · Class A · $695K · 31,683 sh · 10b5-1 |
| Jun 2, 2026Form 4 | Liang JanetPresident, Oscar InsuranceSold · Class A · $274K · 12,475 sh · 10b5-1 |
| Jun 2, 2026Form 4 | McAnaney AdamChief Legal OfficerSold · Class A · $216K · 9,859 sh · 10b5-1 |
| Jun 2, 2026Form 4 | Baltrus VictoriaChief Accounting OfficerSold · Class A · $33K · 1,523 sh · 10b5-1 |
| May 18, 2026Form 4 | Blackley Richard ScottChief Financial OfficerSold · Class A · $2.8M · 110,000 sh · 10b5-1 |
| May 14, 2026Form 4 | Blackley Richard ScottChief Financial OfficerSold · Class A · $2.3M · 100,000 sh · 10b5-1 |
| Apr 6, 2026Form 4 | Bertolini Mark TChief Executive Officer · DirectorBought · Class A · $11.9M · 1,000,000 sh |
| Mar 2, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorSold · Class A · $326K · 24,335 sh · 10b5-1 |
| Mar 2, 2026Form 4 | Blackley Richard ScottChief Financial OfficerSold · Class A · $257K · 19,221 sh · 10b5-1 |
| Mar 2, 2026Form 4 | McAnaney AdamChief Legal OfficerSold · Class A · $251K · 18,710 sh · 10b5-1 |
| Mar 2, 2026Form 4 | Liang JanetPresident, Oscar InsuranceSold · Class A · $100K · 7,453 sh · 10b5-1 |
| Mar 2, 2026Form 4 | Baltrus VictoriaChief Accounting OfficerSold · Class A · $62K · 4,638 sh · 10b5-1 |
| Jan 8, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorSold · Class A · $407K · 23,038 sh · 10b5-1 |
| Jan 6, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorSold · Class A · $1.3M · 76,962 sh · 10b5-1 |
| Jan 5, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorSold · Class A · $1.5M · 96,928 sh · 10b5-1 |
| Jan 2, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorSold · Class A · $2.1M · 137,933 sh · 10b5-1 |
Awards, exercises, withholding and plan purchases · 51 transactions
| Date | Insider |
|---|---|
| Oct 8, 2026Form 4 | Sankaran SidDirectorAward · Deferred Stock Unit · $49K · 1,472 sh |
| Oct 8, 2026Form 4 | Gassen WilliamDirectorAward · Deferred Stock Unit · $23K · 698 sh |
| Oct 8, 2026Form 4 | Plouffe DavidDirectorAward · Deferred Stock Unit · $21K · 641 sh |
| Sep 18, 2026Form 4 | Thrive Partners II GP, LLC, Thrive Capital Partners II, L.P., Thrive Partners III GP, LLC, Thrive Capital Partners III, L.P., Claremount TW, L.P., Thrive Partners VII Growth GP, LLC, Thrive Capital Partners VII Growth, L.P., Thrive Partners VII GP, LLC, Claremount VII Associates, L.P.9 filersOther · Class A · $0 · 19,030,851 sh |
| Sep 18, 2026Form 4 | Kushner JoshuaCo-Founder and Vice Chairman · Director · 10% ownerOther · Class A · $0 · 19,030,851 sh |
| Sep 18, 2026Form 4 | Thrive Partners II GP, LLC, Thrive Capital Partners II, L.P., Thrive Partners III GP, LLC, Thrive Capital Partners III, L.P., Claremount TW, L.P., Thrive Partners VII Growth GP, LLC, Thrive Capital Partners VII Growth, L.P., Thrive Partners VII GP, LLC, Claremount VII Associates, L.P.9 filersOther · Class B · $0 · 12,687,234 sh |
| Sep 18, 2026Form 4 | Kushner JoshuaCo-Founder and Vice Chairman · Director · 10% ownerOther · Class B · $0 · 12,687,234 sh |
| Aug 28, 2026Form 4 | Schlosser MarioDirectorExercise or conversion · Class B · $1.5M · 300,000 sh |
| Aug 28, 2026Form 4 | Schlosser MarioDirectorExercise or conversion · Class A · — · 150,000 sh |
| Aug 28, 2026Form 4 | Schlosser MarioDirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 150,000 sh |
| Aug 27, 2026Form 4 | Schlosser MarioDirectorExercise or conversion · Class B · $5.8M · 1,200,000 sh |
| Aug 27, 2026Form 4 | Schlosser MarioDirectorExercise or conversion · Class A · — · 600,000 sh |
| Aug 27, 2026Form 4 | Schlosser MarioDirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 600,000 sh |
| Jul 9, 2026Form 4 | Sankaran SidDirectorAward · Deferred Stock Unit · $27K · 858 sh |
| Jul 9, 2026Form 4 | Gassen WilliamDirectorAward · Deferred Stock Unit · $21K · 684 sh |
| Jul 9, 2026Form 4 | Plouffe DavidDirectorAward · Deferred Stock Unit · $21K · 681 sh |
| Jul 1, 2026Form 4 | Schlosser MarioDirectorExercise or conversion · Class A · — · 47,500 sh · 10b5-1 |
| Jul 1, 2026Form 4 | Schlosser MarioDirectorExercise or conversion · Class B · $0 · 47,500 sh · 10b5-1 |
| Jun 23, 2026Form 4 | Schlosser MarioDirectorExercise or conversion · Class B · $6.4M · 1,687,500 sh · 10b5-1 |
| Jun 23, 2026Form 4 | Schlosser MarioDirectorExercise or conversion · Class A · — · 1,027,500 sh · 10b5-1 |
| Jun 23, 2026Form 4 | Schlosser MarioDirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 660,000 sh · 10b5-1 |
| Jun 4, 2026Form 4 | WITTMAN VANESSA AMESDirectorAward · Class A · $0 · 8,475 sh |
| Jun 4, 2026Form 4 | Sankaran SidDirectorAward · Class A · $0 · 8,475 sh |
| Jun 4, 2026Form 4 | Lang Laura WDirectorAward · Class A · $0 · 8,475 sh |
| Jun 4, 2026Form 4 | Plouffe DavidDirectorAward · Class A · $0 · 8,475 sh |
| Jun 4, 2026Form 4 | Gassen WilliamDirectorAward · Class A · $0 · 8,475 sh |
| Apr 9, 2026Form 4 | BOYD JEFFERY HDirectorAward · Deferred Stock Unit · $52K · 3,610 sh |
| Apr 9, 2026Form 4 | Plouffe DavidDirectorAward · Deferred Stock Unit · $21K · 1,461 sh |
| Apr 9, 2026Form 4 | Gassen WilliamDirectorAward · Deferred Stock Unit · $21K · 1,418 sh |
| Apr 9, 2026Form 4 | Sankaran SidDirectorAward · Deferred Stock Unit · $17K · 1,203 sh |
| Apr 6, 2026Form 4 | Bertolini Mark TChief Executive Officer · DirectorTax withholding · Class A · $11.9M · 1,000,001 sh |
| Apr 3, 2026Form 4 | Bertolini Mark TChief Executive Officer · DirectorExercise or conversion · Class A · — · 5,733,334 sh |
| Apr 3, 2026Form 4 | Bertolini Mark TChief Executive Officer · DirectorExercise or conversion · Performance Restricted Sto… · $0 · 5,733,334 sh |
| Mar 12, 2026Form 4 | Blackley Richard ScottChief Financial OfficerGift · Class A · $0 · 225,000 sh |
| Mar 2, 2026Form 4 | Bertolini Mark TChief Executive Officer · DirectorAward · Class A · $0 · 1,596,877 sh |
| Mar 2, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorAward · Class A · $0 · 189,141 sh · 10b5-1 |
| Mar 2, 2026Form 4 | Blackley Richard ScottChief Financial OfficerAward · Class A · $0 · 134,847 sh · 10b5-1 |
| Mar 2, 2026Form 4 | Liang JanetPresident, Oscar InsuranceAward · Class A · $0 · 106,458 sh · 10b5-1 |
| Mar 2, 2026Form 4 | McAnaney AdamChief Legal OfficerAward · Class A · $0 · 67,424 sh · 10b5-1 |
| Mar 2, 2026Form 4 | Baltrus VictoriaChief Accounting OfficerAward · Class A · $0 · 17,300 sh · 10b5-1 |
| Jan 8, 2026Form 4 | BOYD JEFFERY HDirectorAward · Deferred Stock Unit · $52K · 3,106 sh |
| Jan 8, 2026Form 4 | Plouffe DavidDirectorAward · Deferred Stock Unit · $21K · 1,257 sh |
| Jan 8, 2026Form 4 | Gassen WilliamDirectorAward · Deferred Stock Unit · $21K · 1,220 sh |
| Jan 8, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorExercise or conversion · Class A · — · 23,038 sh · 10b5-1 |
| Jan 8, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorExercise or conversion · Class B · $0 · 23,038 sh · 10b5-1 |
| Jan 6, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorExercise or conversion · Class A · — · 76,962 sh · 10b5-1 |
| Jan 6, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorExercise or conversion · Class B · $0 · 76,962 sh · 10b5-1 |
| Jan 5, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorExercise or conversion · Class A · — · 86,893 sh · 10b5-1 |
| Jan 5, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorExercise or conversion · Class B · $0 · 86,893 sh · 10b5-1 |
| Jan 2, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorExercise or conversion · Class A · — · 59,800 sh · 10b5-1 |
| Jan 2, 2026Form 4 | Schlosser MarioPresident of Technology & CTO · DirectorExercise or conversion · Class B · $0 · 59,800 sh · 10b5-1 |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 15 filings
| Filed | What it is |
|---|---|
| Sep 16, 20268-K | Regulation FD disclosure |
| Aug 7, 202610-Q | Quarterly report, Q2 2026 — revenue $4.88B (+70% y/y), net income $361.8M, EPS $1.10 |
| Aug 6, 20268-K | Earnings release — EPS $1.10 vs $0.43 est. (+155.8%); revenue $4.88B (+70% y/y) 11.9% |
| Jun 9, 20268-K | Shareholder vote results |
| Jun 8, 20268-K | Regulation FD disclosure |
| Jun 2, 20268-K | Directors or officers; compensation |
| May 7, 202610-Q | Quarterly report, Q1 2026 — revenue $4.65B (+53% y/y), net income $679.0M, EPS $2.07 |
| May 6, 20268-K | Earnings release — EPS $2.07 vs $1.21 est. (+71.1%); revenue $4.65B (+53% y/y) 10.6% |
| Apr 22, 2026ARS | Annual report to shareholders |
| Apr 22, 2026DEFA14A | Additional proxy materials |
| Apr 22, 2026DEF 14A | Proxy statement |
| Apr 21, 20268-K | Oscar Health, Inc. Appoints Director Siddhartha Sankaran as Independent Chair of the BoardRegulation FD disclosure |
| Mar 2, 20268-K | Regulation FD disclosure |
| Feb 13, 202610-K | Annual report, FY2025 — revenue $11.70B (+28% y/y), net income −$443.2M, EPS −$1.69 |
| Feb 10, 20268-K | Earnings release — EPS −$1.24 vs −$0.84 est. (−47.6%); revenue $2.81B (+17% y/y) 1.7% |
2025 · 19 filings
| Filed | What it is |
|---|---|
| Dec 29, 20258-K | Directors or officers; compensation |
| Nov 6, 202510-Q | Quarterly report, Q3 2025 — revenue $2.99B (+23% y/y), net income −$137.4M, EPS −$0.53 |
| Nov 6, 20258-K | Earnings release — EPS −$0.53 vs −$0.55 est. (+3.6%); revenue $2.99B (+23% y/y) 2.8% |
| Sep 18, 20258-K | Material definitive agreement; New financial obligation; Unregistered sale of equity |
| Sep 16, 20258-K | Termination of a material agreement; Other events |
| Sep 15, 20258-K | Material definitive agreement; Regulation FD disclosure; Other events |
| Sep 3, 20258-K | Regulation FD disclosure |
| Aug 7, 202510-Q | Quarterly report, Q2 2025 — revenue $2.86B (+29% y/y), net income −$228.4M, EPS −$0.89 |
| Aug 6, 20258-K | Results of operations |
| Jul 22, 20258-K | Results of operations |
| Jun 6, 20258-K | Shareholder vote results |
| May 8, 202510-Q | Quarterly report, Q1 2025 — revenue $3.05B (+42% y/y), net income $275.3M, EPS $0.92 |
| May 7, 20258-K | Results of operations |
| Apr 25, 2025ARS | Annual report to shareholders |
| Apr 25, 2025DEFA14A | Additional proxy materials |
| Apr 25, 2025DEF 14A | Proxy statement |
| Mar 3, 20258-K | Regulation FD disclosure |
| Feb 20, 202510-K | Annual report, FY2024 — revenue $9.18B (+57% y/y), net income $25.4M, EPS $0.10 |
| Feb 4, 20258-K | Results of operations; Directors or officers; compensation |
2024 · 15 filings
| Filed | What it is |
|---|---|
| Nov 7, 202410-Q | Quarterly report, Q3 2024 — revenue $2.42B (+68% y/y), net income −$54.6M, EPS −$0.22 |
| Nov 7, 20248-K | Results of operations |
| Sep 4, 20248-K | Regulation FD disclosure |
| Aug 7, 202410-Q | Quarterly report, Q2 2024 — revenue $2.22B (+46% y/y), net income $56.2M, EPS $0.20 |
| Aug 7, 20248-K | Results of operations |
| Jun 11, 20248-K | Shareholder vote results |
| Jun 7, 20248-K | Regulation FD disclosure |
| May 7, 202410-Q | Quarterly report, Q1 2024 — revenue $2.14B (+46% y/y), net income $177.4M, EPS $0.62 |
| May 7, 20248-K | Results of operations |
| Apr 25, 2024ARS | Annual report to shareholders |
| Apr 25, 2024DEFA14A | Additional proxy materials |
| Apr 25, 2024DEF 14A | Proxy statement |
| Feb 15, 202410-K | Annual report, FY2023 — revenue $5.86B (+48% y/y), net income −$270.7M, EPS −$1.22 |
| Feb 7, 20248-K | Results of operations |
| Jan 10, 20248-K | Results of operations |
2023 · 20 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
| Filed | What it is |
|---|---|
| Nov 7, 202310-Q | Quarterly report, Q3 2023 — revenue $1.44B (+47% y/y), net income −$65.4M, EPS −$0.29 |
| Aug 9, 202310-Q | Quarterly report, Q2 2023 — revenue $1.52B (+50% y/y), net income −$15.5M, EPS −$0.07 |
| May 10, 202310-Q | Quarterly report, Q1 2023 — revenue $1.47B (+51% y/y), net income −$39.8M, EPS −$0.18 |
| May 10, 202310-K/A | Annual report, amended |
| Apr 27, 2023ARS | Annual report to shareholders |
| Apr 27, 2023DEFA14A | Additional proxy materials |
| Apr 27, 2023DEF 14A | Proxy statement |
| Feb 24, 202310-K | Annual report, FY2022 — revenue $3.96B (+116% y/y), net income −$606.3M, EPS −$2.85 |
12 current reports (8-K) not listed; the year is on EDGAR.
2022 · 22 filings — 15 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms
| Filed | What it is |
|---|---|
| Nov 9, 202210-Q | Quarterly report, Q3 2022 — revenue $978.4M (+120% y/y), net income −$192.9M, EPS −$0.91 |
| Aug 12, 202210-Q | Quarterly report, Q2 2022 — revenue $1.02B, net income −$112.2M, EPS −$0.53 |
| May 24, 2022DEFA14A | Additional proxy materials |
| May 12, 202210-Q | Quarterly report, Q1 2022 — revenue $972.8M (+163% y/y), net income −$75.2M, EPS −$0.36 |
| Apr 26, 2022DEFA14A | Additional proxy materials |
| Apr 26, 2022DEF 14A | Proxy statement |
| Feb 25, 202210-K | Annual report, FY2021 — revenue $1.84B (+297% y/y), net income −$572.6M, EPS −$3.20 |
15 current reports (8-K) not listed; the year is on EDGAR.
2021 · 9 filings — 6 × 8-K, 3 × 10-Q
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 83 filings — 50 × 4, 29 × 144, 2 × SCHEDULE 13G/A and 2 other forms
| Filed | What it is |
|---|---|
| Oct 13, 20264 | Insider transaction (Form 4) |
| Oct 13, 20264 | Insider transaction (Form 4) |
| Oct 13, 20264 | Insider transaction (Form 4) |
| Sep 22, 20264 | Insider transaction (Form 4) |
| Sep 18, 20264 | Insider transaction (Form 4) |
| Sep 18, 20264 | Insider transaction (Form 4) |
| Sep 18, 2026SCHEDULE 13D/A | Other filings |
| Sep 18, 2026144 | Notice of proposed sale (Form 144) |
| Sep 8, 20264 | Insider transaction (Form 4) |
| Sep 8, 20264 | Insider transaction (Form 4) |
| Sep 8, 20264 | Insider transaction (Form 4) |
| Sep 8, 20264 | Insider transaction (Form 4) |
| Sep 8, 20264 | Insider transaction (Form 4) |
| Sep 3, 2026144 | Notice of proposed sale (Form 144) |
| Sep 3, 2026144 | Notice of proposed sale (Form 144) |
| Sep 3, 2026144 | Notice of proposed sale (Form 144) |
| Sep 3, 2026144 | Notice of proposed sale (Form 144) |
| Aug 31, 20264 | Insider transaction (Form 4) |
| Aug 28, 2026144 | Notice of proposed sale (Form 144) |
| Aug 27, 2026144 | Notice of proposed sale (Form 144) |
| Aug 20, 20264 | Insider transaction (Form 4) |
| Aug 20, 2026144 | Notice of proposed sale (Form 144) |
| Aug 18, 2026144 | Notice of proposed sale (Form 144) |
| Aug 13, 2026144 | Notice of proposed sale (Form 144) |
| Aug 10, 2026144 | Notice of proposed sale (Form 144) |
The newest 25 of 83 shown; the full year is on EDGAR.
2025 · 74 filings — 47 × 4, 19 × 144, 4 × SCHEDULE 13G/A and 3 other forms
| Filed | What it is |
|---|---|
| Dec 30, 20254 | Insider transaction (Form 4) |
| Dec 29, 2025144 | Notice of proposed sale (Form 144) |
| Dec 4, 20254 | Insider transaction (Form 4) |
| Dec 4, 20254 | Insider transaction (Form 4) |
| Dec 4, 20254 | Insider transaction (Form 4) |
| Dec 4, 20254 | Insider transaction (Form 4) |
| Dec 4, 20254 | Insider transaction (Form 4) |
| Dec 2, 2025144 | Notice of proposed sale (Form 144) |
| Dec 2, 2025144 | Notice of proposed sale (Form 144) |
| Dec 2, 2025144 | Notice of proposed sale (Form 144) |
| Dec 2, 2025144 | Notice of proposed sale (Form 144) |
| Nov 14, 2025SCHEDULE 13G/A | Other filings |
| Nov 13, 2025SCHEDULE 13G/A | Other filings |
| Nov 13, 20254 | Insider transaction (Form 4) |
| Nov 12, 2025144 | Notice of proposed sale (Form 144) |
| Nov 12, 2025144 | Notice of proposed sale (Form 144) |
| Oct 14, 20254 | Insider transaction (Form 4) |
| Oct 14, 20254 | Insider transaction (Form 4) |
| Oct 14, 20254 | Insider transaction (Form 4) |
| Sep 24, 20254 | Insider transaction (Form 4) |
| Sep 22, 2025144 | Notice of proposed sale (Form 144) |
| Sep 4, 20254 | Insider transaction (Form 4) |
| Sep 4, 20254 | Insider transaction (Form 4) |
| Sep 4, 20254 | Insider transaction (Form 4) |
| Sep 4, 20254 | Insider transaction (Form 4) |
The newest 25 of 74 shown; the full year is on EDGAR.
2024 · 97 filings — 57 × 4, 23 × 144, 12 × SC 13G/A and 4 other forms
| Filed | What it is |
|---|---|
| Dec 9, 20244 | Insider transaction (Form 4) |
| Dec 9, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 3, 20244 | Insider transaction (Form 4) |
| Dec 2, 2024144 | Notice of proposed sale (Form 144) |
| Dec 2, 2024144 | Notice of proposed sale (Form 144) |
| Dec 2, 2024144 | Notice of proposed sale (Form 144) |
| Dec 2, 2024144 | Notice of proposed sale (Form 144) |
| Dec 2, 2024144 | Notice of proposed sale (Form 144) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 22, 20244 | Insider transaction (Form 4) |
| Nov 20, 2024144 | Notice of proposed sale (Form 144) |
| Nov 18, 20244 | Insider transaction (Form 4) |
| Nov 18, 20244 | Insider transaction (Form 4) |
| Nov 14, 20244 | Insider transaction (Form 4) |
| Nov 14, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 14, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Nov 13, 2024SC 13D/A | Active holder above 5% (Schedule 13D), amended |
| Nov 13, 20244 | Insider transaction (Form 4) |
| Nov 13, 20244 | Insider transaction (Form 4) |
The newest 25 of 97 shown; the full year is on EDGAR.
2023 · 72 filings — 45 × 4, 19 × 144, 2 × S-8 and 4 other forms
Counted, not listed; the year is on EDGAR.
2022 · 64 filings — 45 × 4, 6 × SC 13G, 4 × 3 and 4 other forms
Counted, not listed; the year is on EDGAR.
2021 · 86 filings — 37 × 4, 23 × 3, 5 × CORRESP and 15 other forms
Counted, not listed; the year is on EDGAR.
2020 · 6 filings — 2 × DRSLTR, 2 × UPLOAD, 1 × DRS and 1 other form
Counted, not listed; the year is on EDGAR.
2015 · 1 filing — 1 × D
Counted, not listed; the year is on EDGAR.
2014 · 2 filings — 2 × D
Counted, not listed; the year is on EDGAR.
2013 · 1 filing — 1 × D
Counted, not listed; the year is on EDGAR.
About this data#
Oscar Health Inc. (OSCR) has 586 filings on EDGAR going back to 2013: 6 annual reports, 17 quarterly reports and 62 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 13, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Sep 16, 2026, covered regulation fd disclosure. Over the last 13 months insiders sold $142.4M in 31 sales and bought $11.9M in 1 purchase; 51 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Oscar Health Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read OSCR's latest 10-K?
- OSCR's latest annual report, a 10-K, was filed on Feb 13, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did OSCR last file an 8-K?
- On Sep 16, 2026 it covered regulation fd disclosure. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 6, 2026.
- Are OSCR insiders buying or selling?
- Over the last 13 months insiders sold $142.4M in 31 sales and bought $11.9M in 1 purchase; 51 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: WITTMAN VANESSA AMES (Director) sold 25,000 shares on Sep 18, 2026 for $806K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has OSCR made?
- 586 filings are on EDGAR under the registrant records that have been Oscar Health Inc., going back to 2013; 406 of them are insider ownership forms (Forms 3, 4, 5 and 144).